Weed Killer Lawsuit Guide 2025: Glyphosate, Lymphoma, and Damages

## A Cancer Claim Tied to Common Yard Chemicals

Glyphosate-based weed killers are among the most widely used herbicides in the world, applied by farmers, landscapers, groundskeepers, and homeowners. Litigation alleges that long-term exposure to glyphosate is associated with non-Hodgkin lymphoma and that manufacturers failed to warn users of the risk. This is one of the largest and most closely watched product-liability efforts in recent years.

The Core Allegation

Plaintiffs allege that the manufacturer knew of evidence linking glyphosate to cancer, particularly non-Hodgkin lymphoma, yet marketed the product as safe and failed to provide adequate warnings. Some international health bodies classified glyphosate as a probable human carcinogen, while regulators have differed, which is part of why this litigation is hard-fought.

The Primary Injury

The signature diagnosis in this litigation is non-Hodgkin lymphoma (NHL) and certain related blood cancers. Claims are strongest for individuals with substantial, repeated exposure, such as:

• Agricultural workers and farmers.
• Commercial landscapers and groundskeepers.
• Nursery and golf-course workers.
• Heavy residential users over many years.

Who Typically Qualifies

A strong claim generally requires documented, repeated exposure to a glyphosate product over a meaningful period and a diagnosis of non-Hodgkin lymphoma or a qualifying related cancer. Occupational users with years of exposure present the clearest cases, but heavy long-term residential users may also qualify.

Evidence That Supports a Weed Killer Claim

• **Exposure history,** including job records, duration, frequency, and the products used.
• **Purchase records or employer records** documenting use.
• **Medical records and pathology** confirming the NHL diagnosis.
• **Treatment records** such as chemotherapy.

Because exposure often spans years, employment records and consistent product identification strengthen the case.

Who May Be Liable

• **The herbicide manufacturer** for design and failure-to-warn defects.

Settlement and Verdict Ranges

This litigation has produced a wide spectrum of outcomes. Large early jury verdicts reached tens of millions of dollars before reductions, while many claims have been resolved through aggregate settlement programs at lower per-case amounts that vary with exposure and diagnosis severity. Individual injury cases with strong NHL diagnoses and heavy exposure can command six to seven figures, but values depend heavily on the strength of exposure proof and the posture of ongoing litigation.

Steps to Protect a Weed Killer Claim

Step one: document your exposure history, including products, years, frequency, and setting.

Step two: gather employment and purchase records where possible.

Step three: obtain medical records and pathology confirming your diagnosis.

Step four: preserve any product containers you still have.

Step five: consult a [mass tort attorney](/lawyer) active in glyphosate litigation.

Frequently Asked Questions

I only used weed killer occasionally in my yard. Do I qualify? Occasional, light use is a weaker fit than years of heavy or occupational exposure. An attorney can evaluate whether your exposure level supports a claim.

Do I need non-Hodgkin lymphoma specifically? NHL is the signature diagnosis, though some related blood cancers are included. Your diagnosis is central to qualification.

Is it too late to file? Deadlines vary by state and may depend on when you connected your diagnosis to exposure. Because the litigation is active and deadlines apply, consult a [lawyer](/lawyer) promptly.